2026-01-15 - Analysis Report
**Report for Rocket Lab USA Inc (RKLB)**

### Company Overview

Rocket Lab USA Inc is a leading aerospace company specializing in launch services and spacecraft manufacturing.


### Return Rate Comparison

* Cumulative Return of RKLB (review stock) = **578.84%**
* Cumulative Return of VOO (S&P 500, comparison stock) = **48.54%**
* Divergence = **477.80**, Relative Divergence = **98.20%**
* Analysis:
The RKLB stock has shown a significant divergence from the VOO (S&P 500), with an impressive cumulative return of 578.84% compared to 48.54% in the last available data.


### Alpha, Beta, and Capital Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2021-2023  | 3.0% | 48.2% | 3.0% | 1.8 | 3.0B |
| 2022-2024  | 210.0% | 40.8% | 190.0% | 2.0 | 13.6B |
| 2023-2025  | 443.0% | 47.3% | 380.0% | 2.2 | 37.3B |

Analysis:
The company has recorded impressive Alpha values in the last three-year periods (2021-2023, 2022-2024, and 2023-2025), indicating strong returns. Beta, which measures the stock's volatility relative to the S&P 500, has ranged from 1.8 to 2.2, suggesting higher volatility.


### Recent Stock Price Fluctuations

* 5-day SMA = **$86.84**
* 20-day SMA = **$75.56**
* 60-day SMA = **$60.31**

Analysis:
The RKLB stock has shown relatively stable price movements over the short, medium, and long-term periods.


### Technical Indicators

* Market Risk Indicator (MRI) = **0.70**
* RSI = **68.91**
* PPO = **0.70**
* Expected Return (%) = **5.70%**

Analysis:
The MRI indicates a Medium risk level, while RSI and PPO suggest a moderate price movement and stable performance. The Expected Return indicates a promising long-term outlook.


### Recent News & Significant Events (Partial List)

* 2026-01-14 - Rocket Lab: Neutron Euphoria Has Pushed The Stock Into Sell Territory (Rating Downgrade) - Seeking Alpha
* 2026-01-13 - Here's Why Rocket Lab Corporation (RKLB) Fell More Than Broader Market - Yahoo Finance
* 2026-01-14 - Rocket Lab: Premier Alternative To SpaceX in 2026 - Benzinga
* ...and several other news articles

Analysis:
The news articles highlight both positive and negative sentiments about RKLB.


### Analyst Opinions (Summary)

* Analyst Consensus:
 * Key: Buy
 * Mean (1=StrongBuy~5=Sell): **1.73 (~Buy)**
 * Opinions: **13**
 * Target Price (avg/high/low): **$74.04 / $100.00 / $47.00**

Analysis:
Analysts have a generally positive opinion on RKLB, with 13 strong buy recommendations and a target price around $74.04.


### Recent Earnings Analysis (Partial List)

| Date | EPS | Revenue |
|----|----|-------|
| 2025-11-10 | **-0.03** | $**0.16 B** |
| 2025-08-07 | **-0.13** | $**0.14 B** |
| 2025-05-08 | **-0.12** | $**0.12 B** |
| 2024-11-12 | **-0.1** | $**0.10 B** |
| 2025-11-10 | **-0.1** | $**0.10 B** |

Analysis:
RKLB has recorded negative EPS and lower revenue compared to the previous quarterly periods.


### Quarterly Revenue and Profitability Analysis

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $0.16B | 36.96% |
| 2025-06-30 | $0.14B | 32.10% |
| 2025-03-31 | $0.12B | 28.76% |
| 2024-12-31 | $0.13B | 27.81% |
| 2024-09-30 | $0.10B | 26.71% |

Analysis:
The company's revenue has fluctuated over the past year, with a slight increase in the last quarter. Profit margins are relatively stable.


### Quarterly Capital and Profitability Analysis

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $1.28B | -1.43% |
| 2025-06-30 | $0.69B | -9.65% |
| 2025-03-31 | $0.43B | -14.05% |
| 2024-12-31 | $0.38B | -13.69% |
| 2024-09-30 | $0.42B | -12.37% |

Analysis:
The company's equity has fluctuated over the past year, while ROE indicates a negative return on equity for most quarters.


### Comprehensive Analysis

Overall, the RKLB stock has shown impressive returns, a strong Alpha, and a medium risk level. However, recent news articles highlight both positive and negative sentiments, and the company's revenue and profit margins have fluctuated over the past year. Analyst opinions are generally positive, with 13 strong buy recommendations.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.